MEGAN ANDERSON: Open Payments
NPI 1669006359 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 39 payments from 8 companies in 2025. Trend: 2023 $635 · 2024 $644 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $220 |
| Medline Industries LP | 1 | $135 |
| Janssen Pharmaceuticals, Inc | 5 | $90 |
| Neurocrine BioSciences, Inc. | 5 | $75 |
| Alkermes, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| ABBVIE INC. | 3 | $50 |
| Lundbeck LLC | 1 | $14 |
Products named: CAPLYTA, INVEGA SUSTENNA, INGREZZA, ARISTADA, VRAYLAR, ABILIFY MAINTENA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across AR — which companies pay providers there.
